Trial Profile
The effect of GLP-1 in psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov. (NCT01460069)
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov. (NCT01460069)
- 27 Jun 2012 NCT01451905 reports actual initiation date (Aug 2011) and Planned Number of Patients is 12.